Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDON pseudogene 2 (CDONP2) is a non-coding DNA sequence in the human genome that shares high sequence similarity with the CDON gene but does not encode a functional protein. Pseudogenes such as CDONP2 are generally considered to be relics of evolution—remnants of once-functional genes that have accumulated mutations disrupting their coding potential, regulatory elements, or both. Although some pseudogenes may have regulatory RNA roles or influence neighboring genes, there is no evidence in current literature that CDONP2 has any such function or is clinically relevant as a target. CDON pseudogene 2 is not classified as a therapeutic target, receptor, enzyme, transporter, or other functional molecular entity. Clarification: CDONP2 is sometimes confused with CDON (Cell adhesion associated, oncogene regulated), the authentic gene encoding a cell-surface receptor involved in cell-cell interactions and muscle cell differentiation. In contrast, CDONP2 is a pseudogene, meaning it is a defunct genomic element without a protein product and without recognized drug or disease relevance. Summary of Issues: is_incorrect: true because CDONP2 is not a molecular target in the usual sense (i.e., not a receptor, enzyme, transporter, etc.), nor does it possess functional or therapeutic relevance. None of the functional attributes (biological function, disease roles, drug interactions, mechanisms, biomarkers) apply to CDONP2 as of current knowledge. If you seek information about the related functional gene, refer to CDON (Cell adhesion associated, oncogene regulated), which is a real cell-surface receptor with biological and disease associations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDON pseudogene 2 (CDONP2).